IntraBio Inc. today announced that results from its pivotal Phase III clinical trial evaluating levacetylleucine for the treatment of Ataxia-Telangiectasia (A-T) have been published in The Lancet ...
Prime Minister Sir Kier Starmer was challenged to help Jake in the House of Commons ...
Our latest CPD module explores five common but challenging neurology cases encountered in general practice, and discusses evidence-based approaches to assessment, investigation and management.
Did you know you can manage your profile, and explore all of the available newsletters from Kilkenny Live within your account ...
Larimar Therapeutics, Inc. (NASDAQ:LRMR) is one of the Best Small-Cap Growth Stocks to Invest In Now. Recently, on June 19, ...
A little-known, rarely described condition, pseudologia fantastica, could be more prevalent and influential than anyone ...
Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") . Such investors are advised to contact Danielle Peyton at ...
TheFly reported on June 25 that JPMorgan adjusted its price target for LXEO, lowering it to $9 from $12 while maintaining an ...
A father-of-two is preparing to take on a gruelling fitness challenge to raise life-changing money for a teenager he has ...
Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.
Biogen BIIB and Amgen AMGN are two of the biggest biotech companies in the world. Amgen has a strong presence in the oncology ...
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of ...